These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice. Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852 [TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition. Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951 [TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Qian W; Cai X; Qian Q; Zhang W; Wang D J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947 [TBL] [Abstract][Full Text] [Related]
6. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways. Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203 [TBL] [Abstract][Full Text] [Related]
7. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway. Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023 [TBL] [Abstract][Full Text] [Related]
8. [The Study of the Effect and Mechanism of Glucagon Like Peptide-1 in Bleomycin-induced Pulmonary Fibrosis in Mice]. Liu M; Gou S; Chen HT; Chen ZH Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 48(4):509-514. PubMed ID: 28752966 [TBL] [Abstract][Full Text] [Related]
9. β-carboline alkaloids attenuate bleomycin induced pulmonary fibrosis in mice through inhibiting NF-kb/p65 phosphorylation and epithelial-mesenchymal transition. Cui Y; Jiang L; Yu R; Shao Y; Mei L; Tao Y J Ethnopharmacol; 2019 Oct; 243():112096. PubMed ID: 31323300 [TBL] [Abstract][Full Text] [Related]
10. ESL attenuates BLM-induced IPF in mice: Dual mediation of the TLR4/NF-κB and TGF-β1/PI3K/Akt/FOXO3a pathways. Jia C; Yang M; Xiao G; Zeng Z; Li L; Li Y; Jiang J; Xu A; Qiu J; Tang R; Li D; Jia D; Xie C; Wu G; Cai D; Bi X Phytomedicine; 2024 Sep; 132():155545. PubMed ID: 38972238 [TBL] [Abstract][Full Text] [Related]
11. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition. Gao L; Jiang D; Geng J; Dong R; Dai H Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412 [TBL] [Abstract][Full Text] [Related]
12. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways. Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition. Li SR; Tan ZX; Chen YH; Hu B; Zhang C; Wang H; Zhao H; Xu DX Respir Res; 2019 Nov; 20(1):266. PubMed ID: 31775746 [TBL] [Abstract][Full Text] [Related]
14. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658 [TBL] [Abstract][Full Text] [Related]
15. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice. Jin M; Wu Y; Wang L; Zang B; Tan L Phytother Res; 2016 Apr; 30(4):577-87. PubMed ID: 26777519 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of epithelial-to-mesenchymal transition and pulmonary fibrosis by methacycline. Xi Y; Tan K; Brumwell AN; Chen SC; Kim YH; Kim TJ; Wei Y; Chapman HA Am J Respir Cell Mol Biol; 2014 Jan; 50(1):51-60. PubMed ID: 23944988 [TBL] [Abstract][Full Text] [Related]
17. Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo. Wang Y; Li R; Chen L; Tan W; Sun Z; Xia H; Li B; Yu Y; Gong J; Tang M; Ji Y; Yuan S; Shanglong Yao ; Shang Y Shock; 2015 Nov; 44(5):496-502. PubMed ID: 26196843 [TBL] [Abstract][Full Text] [Related]
18. Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis. Tong B; Fu L; Hu B; Zhang ZC; Tan ZX; Li SR; Chen YH; Zhang C; Wang H; Xu DX; Zhao H BMC Pulm Med; 2021 May; 21(1):149. PubMed ID: 33952237 [TBL] [Abstract][Full Text] [Related]
19. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway. Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302 [TBL] [Abstract][Full Text] [Related]
20. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse. Wu Z; Yang L; Cai L; Zhang M; Cheng X; Yang X; Xu J Respir Res; 2007 Jan; 8(1):1. PubMed ID: 17207287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]